What Stereotactic Radiosurgery Really Is
Stereotactic radiosurgery (SRS) is not surgery. No incisions are made. Instead, a machine focuses many narrow radiation beams on one or more tumors from different angles. Where those beams cross, the dose is high enough to damage or destroy the tumor. The surrounding brain tissue receives only a fraction of that dose.
Treatment usually takes one to five sessions, sometimes completed in a single day. Three platforms are most common in clinical practice:
- Gamma Knife: Uses cobalt-60 sources arranged around a helmet-like frame. Widely used for smaller lesions and those near critical brain structures.
- CyberKnife: A robotic arm that moves around the patient, allowing treatment of hard-to-reach locations. Can deliver treatment in multiple smaller sessions, called fractionated SRS.
- LINAC-based systems: Linear accelerators are common in hospital radiation departments. Modern versions with high-precision collimators can achieve results comparable to dedicated SRS devices.
A multi-center planning study comparing these platforms found trade-offs in how precisely dose is shaped and how steeply it falls off at the tumor edge. What matters most is the team's experience, not which platform they use.
Why Center Volume and Experience Matter
High-volume SRS centers have more refined treatment protocols, more experienced radiation oncologists, and dedicated physicists who specialize in complex cases. Experience treating complex cases, such as post-surgical cavities or lesions near the brainstem, may improve outcomes.
A study of cavity-directed SRS at a high-volume center found that complex post-surgical cases can be treated safely with strong local tumor control when the team has deep experience. A prospective national SRS registry tracked quality of life, local control, and overall survival as the primary metrics for evaluating center performance. These are the numbers to ask any center to share before committing to treatment there.
How to Evaluate a Specialized SRS Center
Choosing a center requires more than looking at machine type or institutional reputation. Ask direct questions and expect clear answers. If a center won't share outcome data, that itself is informative.
- Case volume: How many SRS cases for brain metastases does the center treat per year? More experience generally means more refined protocols.
- Team composition: Is there a dedicated neurosurgeon, neuro-oncologist, radiation oncologist, and medical physicist who specialize in brain tumors, not general cancer?
- Outcome data: Can the center share local control rates for brain metastases? Do they participate in a national quality registry such as the NeuroPoint Alliance SRS registry?
- Fractionation options: Can they offer fractionated SRS, treatment spread over a few sessions, for larger lesions or those near sensitive structures?
- Coordination capacity: Will the center send a detailed treatment plan and follow-up imaging schedule back to your local oncologist?
- Clinical trial access: Does the center enroll brain metastases patients in SRS-related trials, giving you access to investigational approaches?
Understanding how SRS compares to whole-brain radiation, and when each is appropriate, is a key part of this evaluation. See our related guide on Stereotactic Radiosurgery vs. Whole Brain Radiation for Brain Metastases: Which Approach Is Right for Your Treatment Plan?
Is Travel to a Specialized Center Worth It?
For some patients, the answer is no. If you have one or two small lesions, your local hospital has an experienced SRS team, and the proposed treatment plan aligns with what a major center would offer, traveling adds cost and fatigue without benefit.
But certain situations make travel worthwhile:
- Four or more brain metastases
- Lesions near critical structures: brainstem, optic nerves, motor cortex, or speech areas
- Post-surgical cavity SRS after removal of a large metastasis
- Recurrent brain metastases if re-irradiation is being considered
- Cases where the only local option offered is whole-brain radiation therapy (WBRT)
- Active systemic therapy, such as immunotherapy or targeted therapy, where timing with radiation requires careful coordination
Your tumor burden, how many metastases you have and how large they are, is central to this decision. See our guide on Single Brain Metastasis vs. Multiple Metastases: Why Your Surgery Candidacy and Radiation Options Change Based on Tumor Burden for information on how tumor number affects your options.
Start With a Remote Second Opinion
Before committing to travel, ask whether a major center offers a remote second opinion. Many do. Dana-Farber's Second Opinion program allows patients from anywhere in the country and abroad to get an expert review without traveling to Boston first. Dana-Farber's Brain Metastases Program coordinates with your primary oncologist wherever they are located, a model increasingly common at major academic centers.
A remote opinion typically requires: prior MRI scans with and without contrast, pathology reports, operative reports if surgery was performed, and a summary of all prior treatments. Processing usually takes one to two weeks. If the remote opinion differs from your local center's recommendation, especially for a complex case, that's a strong signal that traveling for treatment might be worth it.
Mayo Clinic and other major institutions offer multidisciplinary evaluation that helps patients understand the full range of available options before committing to a treatment plan.
Understanding the Cost of SRS
SRS is not inexpensive. Data from national insurance records show that the cost of brain metastasis management per patient is substantial, with SRS costing significantly more per treatment than whole-brain radiation. Add travel, lodging, meals, childcare, and lost work time, and costs add up quickly even for insured patients.
But you need to consider the cost against the benefits. SRS preserves thinking ability better than whole-brain radiation, which helps quality of life and lets patients continue other treatments. Untreated or poorly treated brain metastases have costs too: clinical, functional, and financial.
For a broader picture of brain tumor financial toxicity, see our guide on The Hidden Cost of Brain Tumor Treatment: Insurance Gaps, Out-of-Pocket Expenses, and Financial Assistance Programs Patients Miss.
Insurance and Coverage: What to Know Before You Travel
Coverage for SRS varies widely by insurance plan. Medicare generally covers SRS for brain metastases in patients who meet certain clinical criteria: good performance status, no cancer in the spinal fluid, and no primary diagnosis of lymphoma or certain other tumor types. However, Medicare Advantage plans often apply more restrictive criteria, which may lead to higher rates of initial denial. Private insurers also vary in their coverage.
Before traveling to a specialized center for SRS, take these steps:
- Ask the specialized center's billing team to submit a pre-authorization request to your insurer before scheduling any appointments.
- Request your insurer's coverage criteria for SRS in writing.
- Understand what you'll pay out-of-pocket if the specialized center isn't in your plan's network.
- Ask about the appeals process and what clinical documentation helps with an appeal.
- Ask the center if they have a financial counselor or insurance team to help you.
MSK's insurance and financial assistance program is an example of the navigation support major centers offer. Most large brain tumor programs have similar resources.
Financial Assistance for Travel and Treatment
Several organizations help brain tumor patients pay for travel to specialized care:
- The American Brain Tumor Association's financial assistance page lists travel grants, lodging programs, and emergency financial aid for patients and families.
- The National Brain Tumor Society's financial assistance toolkit lists grants, programs, and medication assistance.
- Many cancer centers partner with local lodging programs for patients receiving multi-day treatment. Ask the social workers at the specialized center about local lodging help.
- The American Cancer Society's Hope Lodge program offers free lodging at select locations near major cancer treatment centers. Check if there's one in your treatment city before making hotel reservations.
- Some nonprofit foundations for specific cancer types, like breast, lung, or melanoma, offer travel grants for patients with brain metastases. Your care team can help you find programs for your cancer type.
How to Coordinate Between Two Care Teams
Traveling for SRS doesn't replace your local oncologist. Your local oncologist stays your main doctor even if you travel for the procedure. You go to another center for SRS, then return home for follow-up and other treatments. That handoff requires clear communication, or it won't happen on its own.
Before SRS at a specialized center:
- Send all prior MRI scans (with and without contrast), pathology reports, operative reports, and treatment summaries to the SRS center before your consultation.
- Ask the SRS team to communicate directly with your local neuro-oncologist or oncologist before finalizing the treatment plan.
- If you're taking systemic therapy (immunotherapy, targeted drugs, or chemotherapy), the SRS team needs to know. The timing of radiation relative to systemic treatment can affect both effectiveness and side effects.
After SRS:
- Ask the SRS center to send a detailed treatment summary to your local team. This should include the dose delivered, number of sessions, lesions treated, and the recommended follow-up imaging schedule.
- Most centers recommend a follow-up MRI at six to eight weeks after SRS, then every two to three months. Make clear which team will order the follow-up scans and what to do if the images raise questions.
- Make sure your local oncologist understands that post-SRS imaging can show treatment-related changes that may look like tumor growth. This distinction is important when deciding whether to change systemic therapy.
Building a Care Team Across Institutions
Many brain metastases patients work with providers at two or more institutions. This is workable, but only if communication is structured. A few practices help:
- Designate one provider at your local hospital as the primary coordinator: the person who gets updates from other centers and follows up if anything is missing.
- Keep a personal medical folder with copies of all imaging reports, treatment summaries, and letters between centers. Bring it to every appointment.
- Before each appointment at either center, confirm that the latest imaging and notes from the other institution have been received and reviewed.
- Ask each center who to call with urgent questions, and how fast they can respond.
A team with a neuro-oncologist, radiation oncologist, neurosurgeon, and primary oncologist is the standard of care for brain metastases. The challenge when that team spans institutions is making sure everyone knows the whole situation.
When to Talk to Your Doctor
Raise the question of a specialized SRS center or a remote second opinion with your oncologist or neuro-oncologist if any of these apply: you're unsure whether your local center has experience with cases like yours; your local center has recommended whole-brain radiation as the primary option and you haven't discussed SRS candidacy; you have four or more brain metastases; your lesions are near critical brain structures; or you've had SRS before and are now considering re-irradiation.
Most oncologists will welcome the question. Asking doesn't mean you distrust them. It means you're taking charge of your care.
This article is for general information and is not a substitute for medical advice. Always consult your oncologist or care team about your specific situation.